deepeye Medical develops AI-driven software to help ophthalmologists and researchers gain actionable insights from retinal imaging and treatment data. Their mission is to improve decisions and outcomes for patients with retinal diseases by providing automated, expert-level second readings and predictions for treatment need.

deepeye offers deepeye® TPS, a CE-marked (Class IIa) medical device software that supports planning of anti-VEGF therapy for neovascular AMD. They also provide a flexible AI research platform for pharmaceutical and device studies to analyze retinal therapy datasets and generate predictive models.

Headquartered in Munich, Germany, deepeye Medical emphasizes regulatory compliance and clinical evidence. For sales and demo requests contact [email protected]. Careers and open positions are listed on their Careers page.